Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 02-10-2012 | Practice Area: | Corporate and M&A |
| Deal Title: | Pfizer Inc. JV with Zhejiang Hisun Pharmaceutical | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Leading international law firm Clifford Chance has advised Pfizer Inc. on its pharmaceutical manufacturing and distribution joint venture with Zhejiang Hisun Pharmaceutical, a leading pharmaceutical company in China listed on the Shanghai Stock Exchange. The companies have established a new pharmaceutical joint venture for the development, production and sale of high quality branded generic drugs for patients in China and global markets. Hisun will own 51% and Pfizer will own 49%. Each party will contribute select existing products, and the parties will also contribute manufacturing sites, cash and other relevant assets. The joint venture will be named Hisun-Pfizer Pharmaceuticals Co., Ltd.
Emma Davies was assisted by Shanghai counsel Campbell Izzard and senior associates Zhang Hong and Yi Yang. Beijing counsel Ninette Dodoo and senior associate Bai Yong advised on the antitrust aspects of the deal.
|
||
| Financial Center: | Hong Kong | Value: | 0.00-0.00 |
| Advised Party: | Joint Venture Party | Law Firm | Clifford Chance |
| JV Party Jurisdiction | China | JV Party Jurisdiction | Switzerland |
| Classification: |
Joint Ventures Continuing Business Partnership |
Lawyer | Emma Davies |
